For the quarter ending 2026-03-31, BJDX had -$260,741 decrease in cash & cash equivalents over the period. $2,990,516 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | 3,499,430 | -1,597,632 | -3,821,039 |
| Depreciation expense | -19,004 | 10,624 | 36,143 |
| Stock-based compensation expense | - | 183 | -251 |
| Non-cash interest expense for notes payable | - | 0 | 0 |
| Amortization of right-of-use asset | -53,310 | 21,000 | 54,105 |
| Write-off and impairment of property and equipment | -34,189 | 36,574 | 495 |
| Deferred offering costs | - | 101,170 | 0 |
| Prepaid expenses and other current assets | 457,168 | -171,727 | -291,460 |
| Other non-current assets | 29,457 | -13,437 | -13,093 |
| Accounts payable | -10,007 | 52,345 | -36,305 |
| Accrued expenses and other current liabilities | 11,972 | 33,119 | 223,387 |
| Net cash used in operating activities | 3,009,505 | -1,359,793 | -3,238,912 |
| Purchase of property and equipment | 18,989 | 0 | 0 |
| Proceeds from sale of property and equipment | 3,675 | - | - |
| Net cash used in investing activities | -15,314 | 0 | 0 |
| Repayment of notes payable | - | 0 | 0 |
| Proceeds from issuance of notes payable, net of discounts of 287,580 | - | 0 | 0 |
| Proceeds from issuance of common stock, gross | -3,721,692 | 0 | 3,846,692 |
| Issuance costs related to issuance of common stock | - | 0 | 464,670 |
| Proceeds from exercise of october 2025 prefunded warrants | 147 | 0 | - |
| Payment of finance lease | -1,943 | 1,015 | 1,979 |
| Net cash provided by (used in) financing activities | -3,254,932 | -1,015 | 3,380,043 |
| Decrease in cash and cash equivalents | -260,741 | -1,360,808 | 141,131 |
| Cash and cash equivalents, beginning of period | 3,082,268 | 4,301,945 | - |
| Cash and cash equivalents, end of period | 3,684,457 | 3,082,268 | - |